Description
HIPAA, GDPR, EU AI ACT | 45 CFR 164.508, 164.502(b), 164.522
HIPAA AI Consent and Disclosure Form Template
Document ID: HEL-AI-CON-001 • Version 1.2
When an AI system processes a patient’s protected health information for a purpose beyond routine treatment, payment, or healthcare operations, HIPAA’s authorization requirement at 45 CFR 164.508 applies, and the organization needs a documented, plain-language disclosure the patient can actually understand. For EU patients, the obligation compounds: GDPR Articles 7, 9, 13, and 22 govern consent, special category health data, transparency, and automated decision-making, while the EU AI Act requires deployers to tell individuals they are subject to a high-risk AI system (Article 26(11)), disclose direct AI interaction (Article 50), and maintain human oversight (Article 14), with Article 13 obliging providers to supply the instructions for use that make that oversight possible. Healthcare AI reaches high-risk status either as a medical device under Article 6(1) and Annex I or through the standalone uses listed in Annex III. A single form that satisfies both regimes prevents the organization from running two disparate disclosure processes for the same AI system.
This form serves two functions in one document: a transparency notice for AI uses that fall under treatment, payment, or healthcare operations, and a formal authorization instrument where HIPAA or GDPR requires one. It walks through AI system identification and description, a checklist of how AI will be used with the patient’s health information (clinical decision support, administrative processing, quality improvement, research, model training), the HIPAA disclosure and authorization section for US patients, a dedicated GDPR and EU AI Act disclosure section for EU subjects, human oversight and the right to human review, consent acknowledgment and selections, the right to revoke consent with a revocation record, and an authorized representative declaration for patients who cannot consent directly. The form makes clear that refusing optional AI uses does not affect the patient’s right to receive care.
What Is Included
US HIPAA Disclosure and Authorization
- AI system identification and description, and permitted-use checklist for the identified system
- HIPAA disclosure and authorization section aligned to 45 CFR 164.508 and the minimum necessary standard (164.502(b))
- Right to request restrictions notice consistent with 45 CFR 164.522
EU Disclosures
- GDPR consent, special category data, and automated decision-making disclosures (Arts. 7, 9, 13, 22)
- EU AI Act disclosures for high-risk healthcare AI: notice that the individual is subject to the system (Art. 26(11)), AI interaction disclosure (Art. 50), and human oversight (Art. 14)
Consent Mechanics
- Human oversight and right to human review section
- Consent acknowledgment and selections, and right to revoke consent with revocation record
- Authorized representative declaration, signatures, revision history, and related documents
Who This Is For
Covered entities and providers deploying clinical decision support, diagnostic AI, or generative documentation tools that touch patient health information, particularly organizations with EU patients or GDPR exposure. Privacy officers and front-desk or intake staff use this to obtain and document patient consent before an AI system is applied to that patient’s care, and to maintain a defensible revocation record if consent is later withdrawn.
This form references the pending January 2025 HHS OCR proposed HIPAA Security Rule update and should be reviewed against the Federal Register final rule once published, alongside the organization’s AI risk tier classifications under the AI Governance Policy (HEL-AI-GOV-001).
Format: Microsoft Word (.docx), fully editable • Delivered as an instant digital download • Document ID: HEL-AI-CON-001
Reviews
There are no reviews yet.